We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
- Authors
Culine, S; Kerbrat, P; Kramar, A; Théodore, C; Chevreau, C; Geoffrois, L; Bui, N B; Pény, J; Caty, A; Delva, R; Biron, P; Fizazi, K; Bouzy, J; Droz, J P; Genito-Urinary Group of the French Federation of Cancer Center (GETUG T93BP)
- Abstract
High cure rates are expected in good-risk metastatic nonseminomatous germ-cell tumor (NSGCT) patients with bleomycin, etoposide and cisplatin.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Vol 18, Issue 5, p917
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1093/annonc/mdm062